1. Home
  2. ULBI vs CMPX Comparison

ULBI vs CMPX Comparison

Compare ULBI & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ultralife Corporation

ULBI

Ultralife Corporation

HOLD

Current Price

$5.44

Market Cap

102.1M

Sector

Miscellaneous

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

N/A

Current Price

$1.85

Market Cap

408.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ULBI
CMPX
Founded
1990
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
102.1M
408.8M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
ULBI
CMPX
Price
$5.44
$1.85
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$14.57
AVG Volume (30 Days)
32.8K
2.4M
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
13.00
N/A
Revenue
$191,159,000.00
N/A
Revenue This Year
$20.00
N/A
Revenue Next Year
N/A
$934.41
P/E Ratio
$0.43
N/A
Revenue Growth
16.24
N/A
52 Week Low
$4.90
$1.61
52 Week High
$8.25
$6.88

Technical Indicators

Market Signals
Indicator
ULBI
CMPX
Relative Strength Index (RSI) 31.26 35.47
Support Level $5.54 $1.88
Resistance Level $5.66 $2.08
Average True Range (ATR) 0.27 0.12
MACD -0.14 -0.06
Stochastic Oscillator 9.33 0.84

Price Performance

Historical Comparison
ULBI
CMPX

About ULBI Ultralife Corporation

Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company also designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: